Results 51 to 60 of about 937 (121)

Time Trends and Predictors of Gout Remission Over 6 Years. [PDF]

Arthritis Care Res (Hoboken)
Tabi-Amponsah AD, Stewart S, Gamble G, Stamp LK, Taylor WJ, Dalbeth N.   +5 more
europepmc   +1 more source

Nanoencapsulated Sirolimus Plus Pegadricase (NASP) in Uncontrolled Gout: Current Status and Future Directions. [PDF]

Drugs
Baraf HSB, Schlesinger N, Strand V.
europepmc   +1 more source

Drug Toxicity and My Dad's Ethnicity. [PDF]

Ann Fam Med
Yoon J, Hirsh DA.
europepmc   +1 more source

Montelukast suppresses NLRP3 inflammasome activation as a potential prophylactic agent against gout arthritis flares

Journal of Inflammation
Shippy, Daniel C., Evered, Abigail H., Ulland, Tyler K.   +2 more
openaire   +2 more sources

Get OUT: Factors Associated With a Longer Length of Stay in Patients Admitted With an Acute Gout Flare, and the Effects of Anakinra on Length of Stay. [PDF]

Int J Rheum Dis
Weerawardena H, Adams CL, Kamalaraj N, Pile K.   +3 more
europepmc   +1 more source

Intra-articular sustained-release colchicine is efficacious in an inflammatory arthritis rat model. [PDF]

RMD Open
Grassot J, Marzouki F, Hervé R, Breckler M, Semerano L, Bessis N, Ea HK, Sanson C, Pouliquen G, Pouletty P, Boissier MC, Rivière E.   +11 more
europepmc   +1 more source

Hyperuricemia as a Ninth Upstream Gate in the Selenoprotein Axis: Uric Acid-Mediated NRF2 Suppression, RAGE-NF-κB Hepcidin Amplification, and Ferroptosis-Driven Hyperuricemic Nephropathy as Three Convergent Mechanisms Connecting Gout to the Selenoprotein Axis Framework

This paper proposes that hyperuricemia represents a ninth upstream gate in the Selenoprotein Axis operating through three simultaneous and non-redundant mechanisms: (1) uric acid-mediated NRF2 suppression reducing GPx4 expression and enabling ferroptosis in renal proximal tubular cells; (2) RAGE-NF-kB activation by urate crystals elevating IL-6 and ...
openaire   +3 more sources

Improvements in Health-Related Quality of Life With Treat-to-Target Urate-Lowering Therapy in Gout: A Post Hoc Analysis of a Randomized Multicenter Trial. [PDF]

Arthritis Care Res (Hoboken)
Barry A, England BR, Sayles H, Helget LN, Androsenko M, Wu H, Michaud K, Kramer B, Newcomb JA, Brophy MT, Davis-Karim A, Ferguson R, Pillinger MH, Neogi T, Palevsky PM, O'Dell JR, Mikuls TR.   +16 more
europepmc   +1 more source

The efficacy and safety of different doses of febuxostat and allopurinol: A meta-analysis. [PDF]

Jt Dis Relat Surg
Zhang F, Wang Y.
europepmc   +1 more source

Quzhuo tongbi formula for reducing gout flare related to uric acid lowering treatment: Study protocol for a multiple-center, randomized, double-blind, placebo, parallel-controlled clinical trial. [PDF]

PLoS One
Pan H, Li X, Wu S, Zhou D, Guan H, Wu H, Wang Q, Tang Y, Hu X, Wang M, Zhou M, Huang R, Liu L, Chen Y, Wen C, Huang L.   +15 more
europepmc   +1 more source